Diplomat dispense Cuvitru to treat primary immunodeficiency


Diplomat corporate headquarters Image: Diplomat

Diplomat Pharmacy is now filling prescriptions for Cuvitru,  immune globulin subcutaneous, which was recently approved by the Food and Drug Administration.

Cuvitru is indicated as a replacement therapy for primary humoral immunodeficiency in adult and pediatric patients 2 years and older.

“We are excited to offer patients a therapy that expands their options for treating primary immunodeficiency,” said Paul Urick, Diplomat’s president.

“Cuvitru is an important treatment for patients with unmet needs,” he added.

There are more than 300 primary immunodeficiency disorders, in which part of the body’s immune system is missing or does not function properly. Normally, the immune system protects the body from pathogenic microorganisms like bacteria, viruses, and fungi, which can cause infectious diseases. When any part of a person’s immune system is absent or dysfunctional, that person is susceptible to and may take longer to recover from infections.

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s